HHS Proposed Rule Change for Federal Workplace Drug Testing Programs

On April 7, 2022, The U.S. Department of Health and Human Services (HHS) proposed a rule change concerning Mandatory Guidelines for Federal Workplace Testing Programs using urine.

HHS specifically proposed revisions to the:

Since the Department of Transportation (DOT) must follow the HHS scientific guidelines for DOT-regulated drug testing laboratory procedures, participants in the DOT transportation industry drug testing program should be aware of the proposed changes being considered by HHS. It should be noted any final rule issued by HHS regarding these proposals may impact the DOT testing program under 49 CFR Part 40, but only after DOT conducts its own rulemaking.

Key takeaways are as follows:

  • Establish a process whereby the department annually publishes the authorized drug testing panel (i.e. drugs, analytes, and cutoffs) to be used for Federal workplace drug testing.
  • Revise the definition of a "substituted" specimen to include specimens with a Bio Marker concentration is inconsistent with that established for human specimens.
  • Update and clarify the oral fluid collection procedures and Revise the Medical Review Officer (MRO) verification process for positive Codeine and Morphine specimens.
  • Require MROs to submit semi-annual reports to the Secretary or Designated HHS representative on Federal agency specimens that were reported as positive for a drug or drug metabolite by a laboratory and verified as negative by the MRO.

DOT is highlighting this notice so that employers, employees and testing service agents may take time to review proposed changes and make and make comment or express any concerns known to HHS on or before June 6, 2022.

If you have any questions, please contact your sales executive, account manager, or our customer service team.

Posted: April 27, 2022

All Rights Reserved © 2022 Business Information Group, Inc.
This document and/or presentation is provided as a service to our customers. Its contents are designed solely for informational purposes, and should not be inferred or understood as legal advice or binding case law, nor shared with any third parties. Persons in need of legal assistance should seek the advice of competent legal counsel. Although care has been taken in preparation of these materials, we cannot guarantee the accuracy, currency or completeness of the information contained within it. Anyone using this information does so at his or her own risk.

Thank you for your interest in Business Information Group. We have received your message and will contact you in one business day or less.
You have exceeded the number of attempts to submit this form. As a result, your IP address has been temporarily blocked.

Get In Touch

Send a Message *fields required

What are your Interests?optional

Contact Information

Even our RFP PROCESS is state-of-the-art.

Take a look

What our clients are saying

We cannot express enough how much we have enjoyed working with BIG! It has really benefitted our processing and ease of doing business!

Licensing and Registration Manager
Investment and Insurance Company

I enjoy collaborating with BIG, and know that if I have to reach out with a question/concern, a positive attitude with a willingness to find resolve is on the other side of an email or a phone call.

Human Resources Administrator
Global Financial Services Firm

You have been the most professional and most helpful business partner that I have ever been associated with — always there to assist us and with rapid turnaround times.

Principal Consultant
Major Professional Services Network

I am confident whenever we add a product with your company that I will have a good experience.

Division Manager
Insurance and Financial Services Agency

We have received superior service and we know this is what you and your team strive for. We are grateful for the dedication, level of professionalism and effort shown.

Large Insurance Agency

You are leaving

Ok, Continue Cancel